Anaphylaxis Following Vaccination

Anaphylaxis is a severe, potentially life-threatening allergic reaction that can occur after vaccination. While rare, anaphylaxis is one of the most serious adverse events monitored by vaccine safety systems worldwide. This page documents the known rates, risk factors, and standard protocols.

Anaphylaxis Rates by Vaccine Type

Anaphylaxis following vaccination is rare. Rates vary by vaccine type:

Source: CDC, FDA, and published literature. Rates may vary by surveillance method.

Risk Factors

• Prior anaphylaxis: History of anaphylaxis to vaccine components is the strongest risk factor
• Allergies: Individuals with documented allergies to vaccine ingredients (e.g., polyethylene glycol, polysorbate 80) have higher risk
• Previous allergic reactions: History of allergic reactions to other injections
• Age and sex: Some data suggest slightly higher rates in younger adults and females

Standard Observation Protocol

CDC and WHO recommend observation periods after vaccination:

• Standard vaccines: 15-30 minute observation for most vaccines
• COVID-19 mRNA vaccines: 15-30 minute observation (increased to 30 minutes for those with history of anaphylaxis)
• First-time recipients of new vaccines: Extended observation may be recommended

Comparison to Other Medical Interventions

Anaphylaxis risk from vaccines compares favorably to other common medical interventions:

• Penicillin antibiotics: 1-5 per 10,000 doses (much higher than any vaccine)
• General anesthesia: 1-5 per 10,000 procedures
• Contrast dyes (imaging): 0.2-3.0 per 10,000 doses
• Blood transfusions: 1-3 per 100,000 units

Sources & Citations

• CDC: Anaphylaxis Guidelines
• CDC: Managing Anaphylaxis